Universe Pharmaceuticals Inc. UPC NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • CN • USD

SharesGrow Score

29/100

0/5 Pass

SharesGrow Intrinsic Value

N/A

Negative cash flow

SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Universe Pharmaceuticals Inc. (UPC) has a negative trailing P/E of -0.5, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -222.09%.

Criteria proven by this page:

VALUE (0/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -0.5); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -222.09%).
Trailing Earnings Yield -222.09% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.

Overall SharesGrow Score: 28/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score

29/100

SG Score

View full scorecard →

—

VALUE

N/A

No coverage

—

FUTURE

N/A

No coverage

✗

PAST

0/100

→ Income

HEALTH

67/100

Debt-to-Equity & liquidity

→ Health

✗

MOAT

21/100

→ Income

GROWTH

48/100

→ Income

✗

INCOME

10/100

→ Income

Valuation Snapshot — UPC

Valuation Multiples

P/E (TTM)-0.5

Forward P/EN/A

PEG RatioN/A

Forward PEGN/A

P/B Ratio0.03

P/S Ratio0.09

EV/EBITDA7.8

Per Share Data

EPS (TTM)$-6.52

Book Value / Share$99.64

Revenue / Share$31.70

FCF / Share$-9.44

Yields & Fair Value

Earnings Yield-222.09%

Dividend Yield0.00%

Historical Valuation

Year	P/E (TTM)	PEG Ratio	P/B Ratio	P/S Ratio	Dividend Yield
2018	13.1	0.00	10.30	3.50	3.07%
2019	13.2	-19.52	8.05	3.00	16.05%
2020	13.2	147.27	4.79	3.25	-
2021	4.1	0.06	0.80	0.98	-
2022	-1.4	0.01	0.26	0.30	-
2023	-0.5	0.02	0.09	0.10	-
2024	-0.1	0.00	0.02	0.04	-
2025	0.0	0.00	0.00	0.00	-

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year	EPS (Diluted)	Revenue	Net Income	Net Margin
2018	$0.36	$28.51M	$7.6M	26.7%
2019	$0.36	$33.23M	$7.55M	22.7%
2020	$2.06	$30.7M	$7.56M	24.6%
2021	$3.12	$47.98M	$11.32M	23.6%
2022	$-2.41	$40.14M	$-8.74M	-21.8%
2023	$-1.70	$32.31M	$-6.16M	-19.1%
2024	$-2.39	$23.02M	$-8.73M	-37.9%
2025	$-1,055.75	$17.86M	$-3.67M	-20.6%